|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A01N 37/34 | |
| A61K 31/275 | |||
| C07D 231/12 | |||
| C07D 307/79 | |||
| C07D 405/06 | |||
| C07D 405/12 | |||
| C07D 405/14 | |||
| C07D 409/12 | |||
| C07D 417/12 | |||
| C07D 417/14 |
| (11) | Number of the document | 2257160 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09712269.1 |
| Date of filing the European patent application | 2009-02-23 | |
| (97) | Date of publication of the European application | 2010-12-08 |
| (45) | Date of publication and mention of the grant of the patent | 2017-07-05 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2009/034917 |
| Date | 2009-02-23 |
| (87) | Number | WO 2009/105776 |
| Date | 2009-08-27 |
| (30) | Number | Date | Country code |
| 30541 | 2008-02-21 | US |
| (72) |
EISSENSTAT, Michael, US
DUAN, Dehui, US
|
| (73) |
Sequoia Pharmaceuticals, Inc.,
10388 Stanmore Drive, Potomac, MD 20854,
US
|
| (54) | DIAMIDE INHIBITORS OF CYTOCHROME P450 |
| DIAMIDE INHIBITORS OF CYTOCHROME P450 |